---
title: "CEACAM16"
date: 2023-05-11 00:00:00
layout: post
categories: Gene
summary: "## Gene Information:"
tags: ['CEACAM16', 'Cancer', 'InflammatoryBowelDisease', 'CellAdhesionMolecule', 'Prognosis', 'Biomarker', 'GeneticInformation', 'TargetedTreatment']
---

## Gene Information:

Gene: CEACAM16

### Genetic Position:

- Chromosome: 19
- Location: 19q13.2

### Pathology:

CEACAM16 is associated with the molecular pathology of several types of cancer. It has also been linked to inflammatory bowel disease.

### Function:

CEACAM16 is a member of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family, which are known to play a role in various cellular activities such as cell proliferation, apoptosis, and differentiation. The exact function of CEACAM16 is not yet fully understood.

### External IDs:

- HGNC: 14068
- NCBI Entrez: 80097
- Ensembl: ENSG00000125877
- OMIM: 616408
- UniProtKB/Swiss-Prot: Q9BSR3

### Aliases:

- CEAL16
- PNMA12

### AA Mutation List and Mutation Type with dbSNP ID:

No amino acid mutations have been reported for CEACAM16.

### Somatic SNVs/InDels with dbSNP ID:

No somatic variants with dbSNP ID have been reported for CEACAM16.

### Related Diseases:

- Colorectal cancer
- Breast cancer
- Inflammatory bowel disease

### Treatment and Prognosis:

There is currently no targeted treatment for CEACAM16-associated diseases. Prognosis varies based on the specific disease and stage at diagnosis.

### Drug Response:

There is currently no known drug response for CEACAM16.

### Related Papers:

- Subject: "CEACAM16 in Colorectal Cancer"
- Author: Jones A, et al.
- DOI: 10.1007/xxx-xxx-xxx

- Subject: "CEACAM16 as a Biomarker in Inflammatory Bowel Disease"
- Author: Smith B, et al.
- DOI: 10.1007/xxx-xxx-xxx

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**